Clinical

Dataset Information

0

Phase II study of first line chemotherapy with UFT/LV in elderly patients with advanced/recurrent colorectal cancer.


ABSTRACT: Interventions: UFT 300mg/m2/day and LV 75mg/body/day is administered orally for 28 days every 35 days. Primary outcome(s): response rate Study Design: Single arm Non-randomized

DISEASE(S): Advanced/recurrent Colorectal Cancer

PROVIDER: 2622557 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2631332 | ecrin-mdr-crc
| 2618840 | ecrin-mdr-crc
| 2624363 | ecrin-mdr-crc
| 2618974 | ecrin-mdr-crc
| 2623111 | ecrin-mdr-crc
| 2617052 | ecrin-mdr-crc
| 2618906 | ecrin-mdr-crc
| 2625971 | ecrin-mdr-crc
| 2620921 | ecrin-mdr-crc
| 2614185 | ecrin-mdr-crc